New framework agreement concluded with AstraZeneca


International technology company Semcon, developer of products based on human needs and behaviours has signed the agreement with the multinational pharmaceutical company

New framework agreement concluded with AstraZeneca

Technology company Semcon is increasing its focus on life sciences. Smart technical solutions can be used to improve care and welfare for patients and healthcare staff alike. A new framework agreement has also been concluded with AstraZeneca, applicable to everything from product and production development to product information.

“We have extensive experience of life sciences, developing digital solutions that add a great deal of value in the field of healthcare, for instance. We have seen good results from our previous partnership with AstraZeneca, and we are pleased that they have chosen to carry on developing this partnership with us,” said Markus Granlund, President and CEO at Semcon.

The digitisation of the field of life sciences is making increasing demands of expertise in fields such as smart production solutions and data integrity for future connected production and handling of medications. Making processes efficient is every bit as important as making them safe.

“Our in-depth knowledge of the entire product development cycle gives us a turnkey offering that is unique. Moreover, we can take our experience of other industries and apply it in the field of life sciences. But above all, human needs and behaviours always come first as far as we are concerned. This is a prerequisite for success,” said Markus Granlund.

In connection with the new framework agreement, Semcon will be opening another office in Södertälje in October, focusing specifically on life sciences. This office will be situated in the heart of Södertälje and around 50 people will be linked with it.

Sign up for your free email newsletter

“Our new office will give us the opportunity to get even closer to our customers, and this initiative will allow us to carry on expanding in the field of life sciences, where we perceive some excellent opportunities for the future,” said Sara Sjögren, Division Manager.